The global demand for Dydrogesterone API continues to grow as pharmaceutical companies expand their women’s healthcare portfolios. From fertility support to hormone replacement therapy, this API has become an essential active pharmaceutical ingredient for manufacturers developing high-quality hormonal formulations.

Dydrogesterone API – Key Information

  • Product Name: Dydrogesterone API
  • Generic Name: Dydrogesterone
  • CAS Number: 152-62-5
  • Molecular Formula: C₂₁H₂₈O₂
  • Molecular Weight: 312.45 g/mol

As regulatory expectations evolve across Europe and Russia, sourcing this API from a reliable manufacturer with DMF and CEP, GMP compliance, and consistent quality has become a strategic business decision. Amber Lifesciences supports pharmaceutical companies with dependable API manufacturing, comprehensive regulatory documentation, and international export capabilities.

What is Dydrogesterone API?

It is a synthetic progestogen that closely resembles the activity of natural progesterone while offering excellent oral bioavailability. Due to its selective progesterone receptor activity, it is widely used in the treatment of various gynecological and reproductive health conditions.

Its efficacy, safety profile, and clinical acceptance have made Dydrogesterone API an important ingredient in modern hormonal therapies. As a specialized Hormonal API manufacturer, Amber Lifesciences focuses on manufacturing high-quality APIs that meet the stringent requirements of regulated pharmaceutical markets.

Therapeutic Applications of Dydrogesterone API

The demand for Dydrogesterone API continues to increase because of its extensive use in women’s healthcare formulations. Growing awareness of reproductive health and increasing fertility treatments continue to fuel this global demand.

Major therapeutic applications include:

  • Infertility treatment and luteal phase support
  • Recurrent miscarriage management
  • Threatened miscarriage support
  • Menstrual disorders
  • Endometriosis
  • Dysmenorrhea
  • Secondary amenorrhea
  • Hormone Replacement Therapy (HRT)

Why Demand is Growing in Europe and Russia

Europe and Russia remain important markets for hormonal therapies and women’s health pharmaceuticals. Increasing healthcare investments, growing infertility treatment programs, and rising awareness of reproductive health are driving the demand for Dydrogesterone API in Europe and Russia.

Key growth drivers include rising infertility treatment cycles, increased diagnosis of hormonal disorders, expanding hormone replacement therapy programs, and a strong regulatory focus on product quality and compliance. To meet these expectations, pharmaceutical companies increasingly seek reliable suppliers capable of providing consistent product quality along with complete regulatory documentation.

Why Source Dydrogesterone API from India?

India has become one of the world’s leading pharmaceutical manufacturing hubs. Today, many international companies source API from India because of its high manufacturing standards, regulatory expertise, and cost-effective production.

Key advantages include:

  • WHO GMP-compliant manufacturing facilities
  • Availability of DMF and CEP-supported APIs
  • Advanced pharmaceutical manufacturing infrastructure
  • Competitive pricing without compromising quality
  • Strong regulatory and technical expertise
  • Reliable global export network

How to Choose the Right API Manufacturer

Selecting the right Dydrogesterone API manufacturer involves much more than evaluating pricing. Procurement teams should assess suppliers based on quality systems, regulatory readiness, manufacturing capabilities, and long-term reliability.

Important evaluation criteria include:

  • GMP-certified manufacturing facilities
  • High-purity and consistent batch quality
  • Availability of Drug Master File (DMF) and Certificate of Suitability (CEP)
  • Complete documentation, including CoA, specifications, and stability data
  • Robust quality assurance and quality control systems
  • Scalable manufacturing capacity and reliable export experience

Amber Lifesciences: A Trusted Dydrogesterone API Manufacturer

Amber Lifesciences is an Indian Dydrogesterone manufacturer specializing in high-quality hormonal active pharmaceutical ingredients. The company combines advanced manufacturing capabilities with strict quality systems to deliver APIs that meet international regulatory expectations.

Our offers:

  • High-purity API with DMF and CEP for regulated markets
  • GMP-compliant manufacturing with consistent batch-to-batch quality
  • Comprehensive international documentation (CoA, specifications, technical dossiers)
  • Reliable export capabilities across Europe, Russia, and global markets
  • Customer-focused technical and regulatory support

Quality, Compliance, and Regulatory Excellence

Quality and regulatory compliance remain critical when sourcing API. Every batch from Amber Lifesciences is supported by comprehensive documentation. This documentation helps pharmaceutical companies streamline regulatory submissions while ensuring confidence in product quality, traceability, and supply continuity.

Partner with Amber Lifesciences

Today’s pharmaceutical companies seek strategic manufacturing partners rather than transactional suppliers. A reliable manufacturer can help accelerate product registrations, reduce regulatory complexity, and strengthen supply chain resilience.

If your organization is looking for a reliable Dydrogesterone API manufacturer or long-term Pharmaceutical API supplier, Amber Lifesciences is ready to support your sourcing requirements. Contact our team to request samples, technical dossiers, DMF and CEP documentation, or commercial quotations. We look forward to building long-term partnerships with pharmaceutical manufacturers, CDMOs, CMOs, and procurement teams across Europe and Russia.

Frequently Asked Questions (FAQs)

1. Why choose Amber Lifesciences for Dydrogesterone API?

Amber Lifesciences provides high-quality API solutions backed by consistent manufacturing standards, reliable supply capabilities, regulatory documentation support, competitive pricing, and customer-focused technical assistance for pharmaceutical companies in global markets.

2. What quality standards should pharmaceutical companies consider when sourcing hormonal APIs?

Pharmaceutical companies should evaluate GMP compliance, product purity, batch-to-batch consistency, manufacturing controls, quality documentation, regulatory support, and the supplier’s ability to meet applicable market-specific requirements.

3. What regulatory documentation should API buyers request from a supplier?

Depending on the product and target market, buyers may require documents such as a Certificate of Analysis (CoA), specifications, GMP documentation, safety data, stability information, and relevant regulatory dossiers such as a DMF or CEP, where applicable.

4. How important is supply chain reliability when selecting an API manufacturer?

A reliable supply chain helps formulation manufacturers maintain production schedules and reduce procurement risks. Buyers should assess manufacturing capacity, lead times, logistics capabilities, inventory planning, and the supplier’s experience with international shipments.

5. Why do pharmaceutical companies source APIs from India?

India is a major global pharmaceutical manufacturing hub with extensive API production capabilities, technical expertise, established quality systems, and competitive manufacturing costs. Indian suppliers serve regulated and emerging pharmaceutical markets worldwide.